Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

More On 1093.HK



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


CSPC Pharmaceutical Group Limited (1093.HK)

6.43 Down 0.02(0.31%) Jul 25, 3:59AM EDT
ProfileGet Profile for:
CSPC Pharmaceutical Group Limited
Central Plaza
32nd Floor
Wan Chai,
Hong Kong - Map

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:10,390

Business Summary 

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs. In addition, it researches and develops approximately 170 products for therapeutic areas of anti-infective, cardio-cerebrovascular, diabetes, neurology, and oncology. Further, the company offers pharmaceutical research and development services; and sewage treatment services. It has operations primarily in the People’s Republic of China, other Asian regions, the Americas, and Europe. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. The company is based in Wan Chai, Hong Kong and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange.

Key Statistics

Company Websites 
No websites available for 1093.HK
Search Yahoo! for:
More on CSPC Pharmaceutical Group Limited

Key Executives 
Mr. Dongchen Cai , 60
Exec. Chairman, Chief Exec. Officer, Managing Director and Chairman of Nomination Committee
Mr. Weidong Pan , 44
Chief Accountant, Exec. Director and Director of Shijiazhuang Pharmaceutical Group Company Limite
Mr. Zhenying Feng , 58
Exec. Director
Mr. Kin Man Chak , 48
Exec. Director
Mr. Ling Huan Zhao , 51
Exec. Director
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in HKD.